cik stringlengths 10 10 | companyName stringlengths 5 60 | ticker stringlengths 1 7 ⌀ | exchange stringclasses 3
values | sic stringdate 0100-01-01 00:00:00 8744-01-01 00:00:00 ⌀ | sicDescription stringclasses 174
values | stateOfIncorporation stringclasses 52
values | fiscalYearEnd stringdate 0101-01-01 00:00:00 1231-01-01 00:00:00 ⌀ | entityType stringclasses 3
values | accessionNumber stringlengths 20 20 | formType stringclasses 22
values | filingDate timestamp[s]date 2023-01-31 00:00:00 2026-07-31 00:00:00 | reportDate timestamp[s]date 2022-12-31 00:00:00 2026-07-30 00:00:00 ⌀ | acceptanceDateTime stringlengths 24 24 ⌀ | items stringclasses 60
values | fileNumber stringlengths 9 13 ⌀ | sizeBytes int64 3.99k 177M ⌀ | isXBRL bool 2
classes | primaryDocument stringlengths 9 36 | primaryDocDescription stringclasses 89
values | filingIndexUrl stringlengths 94 97 | documentUrl stringlengths 75 103 | matchedFullTextQuery stringclasses 12
values | retrievedAt timestamp[s]date 2026-08-02 21:56:15 2026-08-02 23:14:36 | _run_id stringclasses 63
values | _dataset_id stringclasses 63
values | financials unknown |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0001614556 | Star Alliance International Corp. | null | null | 1040 | Gold and Silver Ores | NV | 0630 | operating | 0001683168-25-000337 | 10-K/A | 2025-01-14T00:00:00 | 2023-06-30T00:00:00 | 2025-01-14T16:55:39.000Z | null | 000-56620 | 18,461,281 | true | staralliance_i10ka1-063023.htm | FORM 10-K FOR JUNE 2023 AMENDMENT 1 | https://www.sec.gov/Archives/edgar/data/1614556/000168316825000337/0001683168-25-000337-index.htm | https://www.sec.gov/Archives/edgar/data/1614556/000168316825000337/staralliance_i10ka1-063023.htm | null | 2026-08-02T22:32:36 | xI3v936aV1gOIDRDn | U3Egsyeael3kbbfsP | null |
0001533615 | Chiron Real Estate Inc. | XRN | NYSE | 6798 | Real Estate Investment Trusts | MD | 1231 | operating | 0001104659-26-021956 | 10-K | 2026-03-02T00:00:00 | 2025-12-31T00:00:00 | 2026-03-02T14:01:20.000Z | null | 001-37815 | 19,759,911 | true | xrn-20251231x10k.htm | 10-K | https://www.sec.gov/Archives/edgar/data/1533615/000110465926021956/0001104659-26-021956-index.htm | https://www.sec.gov/Archives/edgar/data/1533615/000110465926021956/xrn-20251231x10k.htm | null | 2026-08-02T22:32:26 | yCAJcI9WPEgB7Jgu4 | t1OU8ZW9gS4Pwid9U | null |
0001533615 | Chiron Real Estate Inc. | XRN | NYSE | 6798 | Real Estate Investment Trusts | MD | 1231 | operating | 0001558370-25-001938 | 10-K | 2025-02-28T00:00:00 | 2024-12-31T00:00:00 | 2025-02-28T21:05:46.000Z | null | 001-37815 | 18,308,763 | true | gmre-20241231x10k.htm | 10-K | https://www.sec.gov/Archives/edgar/data/1533615/000155837025001938/0001558370-25-001938-index.htm | https://www.sec.gov/Archives/edgar/data/1533615/000155837025001938/gmre-20241231x10k.htm | null | 2026-08-02T22:32:26 | yCAJcI9WPEgB7Jgu4 | t1OU8ZW9gS4Pwid9U | null |
0000860546 | COPT DEFENSE PROPERTIES | CDP | NYSE | 6798 | Real Estate Investment Trusts | MD | 1231 | operating | 0000860546-26-000011 | 10-K | 2026-02-20T00:00:00 | 2025-12-31T00:00:00 | 2026-02-20T21:57:56.000Z | null | 001-14023 | 22,096,319 | true | cdp-20251231.htm | 10-K | https://www.sec.gov/Archives/edgar/data/860546/000086054626000011/0000860546-26-000011-index.htm | https://www.sec.gov/Archives/edgar/data/860546/000086054626000011/cdp-20251231.htm | null | 2026-08-02T22:32:26 | yCAJcI9WPEgB7Jgu4 | t1OU8ZW9gS4Pwid9U | null |
0000860546 | COPT DEFENSE PROPERTIES | CDP | NYSE | 6798 | Real Estate Investment Trusts | MD | 1231 | operating | 0000860546-25-000008 | 10-K | 2025-02-21T00:00:00 | 2024-12-31T00:00:00 | 2025-02-21T21:19:41.000Z | null | 001-14023 | 22,624,127 | true | ofc-20241231.htm | 10-K | https://www.sec.gov/Archives/edgar/data/860546/000086054625000008/0000860546-25-000008-index.htm | https://www.sec.gov/Archives/edgar/data/860546/000086054625000008/ofc-20241231.htm | null | 2026-08-02T22:32:26 | yCAJcI9WPEgB7Jgu4 | t1OU8ZW9gS4Pwid9U | null |
0000104894 | Elme Communities | ELME | NYSE | 6798 | Real Estate Investment Trusts | MD | 1231 | operating | 0000104894-26-000015 | 10-K/A | 2026-04-28T00:00:00 | 2025-12-31T00:00:00 | 2026-04-28T20:06:56.000Z | null | 001-06622 | 4,036,982 | true | elme-20251231.htm | 10-K/A | https://www.sec.gov/Archives/edgar/data/104894/000010489426000015/0000104894-26-000015-index.htm | https://www.sec.gov/Archives/edgar/data/104894/000010489426000015/elme-20251231.htm | null | 2026-08-02T22:32:27 | yCAJcI9WPEgB7Jgu4 | t1OU8ZW9gS4Pwid9U | null |
0000104894 | Elme Communities | ELME | NYSE | 6798 | Real Estate Investment Trusts | MD | 1231 | operating | 0000104894-26-000011 | 10-K | 2026-02-27T00:00:00 | 2025-12-31T00:00:00 | 2026-02-27T21:05:22.000Z | null | 001-06622 | 11,150,129 | true | elme-20251231.htm | 10-K | https://www.sec.gov/Archives/edgar/data/104894/000010489426000011/0000104894-26-000011-index.htm | https://www.sec.gov/Archives/edgar/data/104894/000010489426000011/elme-20251231.htm | null | 2026-08-02T22:32:27 | yCAJcI9WPEgB7Jgu4 | t1OU8ZW9gS4Pwid9U | null |
0000034903 | FEDERAL REALTY INVESTMENT TRUST | FRT | NYSE | 6798 | Real Estate Investment Trusts | MD | 1231 | operating | 0000034903-26-000017 | 10-K | 2026-02-12T00:00:00 | 2025-12-31T00:00:00 | 2026-02-12T21:12:08.000Z | null | 001-07533 | 17,805,531 | true | frt-20251231.htm | 10-K | https://www.sec.gov/Archives/edgar/data/34903/000003490326000017/0000034903-26-000017-index.htm | https://www.sec.gov/Archives/edgar/data/34903/000003490326000017/frt-20251231.htm | null | 2026-08-02T22:32:27 | yCAJcI9WPEgB7Jgu4 | t1OU8ZW9gS4Pwid9U | null |
0000034903 | FEDERAL REALTY INVESTMENT TRUST | FRT | NYSE | 6798 | Real Estate Investment Trusts | MD | 1231 | operating | 0000034903-25-000016 | 10-K | 2025-02-13T00:00:00 | 2024-12-31T00:00:00 | 2025-02-13T21:13:16.000Z | null | 001-07533 | 17,542,750 | true | frt-20241231.htm | 10-K | https://www.sec.gov/Archives/edgar/data/34903/000003490325000016/0000034903-25-000016-index.htm | https://www.sec.gov/Archives/edgar/data/34903/000003490325000016/frt-20241231.htm | null | 2026-08-02T22:32:27 | yCAJcI9WPEgB7Jgu4 | t1OU8ZW9gS4Pwid9U | null |
0001070750 | HOST HOTELS & RESORTS, INC. | HST | Nasdaq | 6798 | Real Estate Investment Trusts | MD | 1231 | operating | 0001070750-26-000054 | 10-K | 2026-02-25T00:00:00 | 2025-12-31T00:00:00 | 2026-02-25T20:33:14.000Z | null | 001-14625 | 23,203,565 | true | hst-20251231.htm | 10-K | https://www.sec.gov/Archives/edgar/data/1070750/000107075026000054/0001070750-26-000054-index.htm | https://www.sec.gov/Archives/edgar/data/1070750/000107075026000054/hst-20251231.htm | null | 2026-08-02T22:32:29 | yCAJcI9WPEgB7Jgu4 | t1OU8ZW9gS4Pwid9U | null |
0001070750 | HOST HOTELS & RESORTS, INC. | HST | Nasdaq | 6798 | Real Estate Investment Trusts | MD | 1231 | operating | 0001070750-25-000071 | 10-K | 2025-02-26T00:00:00 | 2024-12-31T00:00:00 | 2025-02-26T16:13:39.000Z | null | 001-14625 | 21,727,531 | true | hst-20241231.htm | 10-K | https://www.sec.gov/Archives/edgar/data/1070750/000107075025000071/0001070750-25-000071-index.htm | https://www.sec.gov/Archives/edgar/data/1070750/000107075025000071/hst-20241231.htm | null | 2026-08-02T22:32:29 | yCAJcI9WPEgB7Jgu4 | t1OU8ZW9gS4Pwid9U | null |
0001689796 | JBG SMITH Properties | JBGS | NYSE | 6798 | Real Estate Investment Trusts | MD | 1231 | operating | 0001104659-26-016450 | 10-K | 2026-02-17T00:00:00 | 2025-12-31T00:00:00 | 2026-02-17T21:18:51.000Z | null | 001-37994 | 22,587,643 | true | jbgs-20251231x10k.htm | 10-K | https://www.sec.gov/Archives/edgar/data/1689796/000110465926016450/0001104659-26-016450-index.htm | https://www.sec.gov/Archives/edgar/data/1689796/000110465926016450/jbgs-20251231x10k.htm | null | 2026-08-02T22:32:29 | yCAJcI9WPEgB7Jgu4 | t1OU8ZW9gS4Pwid9U | null |
0001689796 | JBG SMITH Properties | JBGS | NYSE | 6798 | Real Estate Investment Trusts | MD | 1231 | operating | 0001558370-25-001099 | 10-K | 2025-02-18T00:00:00 | 2024-12-31T00:00:00 | 2025-02-18T21:16:27.000Z | null | 001-37994 | 22,623,080 | true | jbgs-20241231x10k.htm | 10-K | https://www.sec.gov/Archives/edgar/data/1689796/000155837025001099/0001558370-25-001099-index.htm | https://www.sec.gov/Archives/edgar/data/1689796/000155837025001099/jbgs-20241231x10k.htm | null | 2026-08-02T22:32:29 | yCAJcI9WPEgB7Jgu4 | t1OU8ZW9gS4Pwid9U | null |
0000888491 | OMEGA HEALTHCARE INVESTORS INC | OHI | NYSE | 6798 | Real Estate Investment Trusts | MD | 1231 | operating | 0000888491-26-000008 | 10-K | 2026-02-09T00:00:00 | 2025-12-31T00:00:00 | 2026-02-09T15:58:21.000Z | null | 001-11316 | 32,188,247 | true | ohi-20251231x10k.htm | 10-K | https://www.sec.gov/Archives/edgar/data/888491/000088849126000008/0000888491-26-000008-index.htm | https://www.sec.gov/Archives/edgar/data/888491/000088849126000008/ohi-20251231x10k.htm | null | 2026-08-02T22:32:30 | yCAJcI9WPEgB7Jgu4 | t1OU8ZW9gS4Pwid9U | null |
0000888491 | OMEGA HEALTHCARE INVESTORS INC | OHI | NYSE | 6798 | Real Estate Investment Trusts | MD | 1231 | operating | 0000888491-25-000006 | 10-K | 2025-02-13T00:00:00 | 2024-12-31T00:00:00 | 2025-02-13T15:36:12.000Z | null | 001-11316 | 36,878,859 | true | ohi-20241231x10k.htm | 10-K | https://www.sec.gov/Archives/edgar/data/888491/000088849125000006/0000888491-25-000006-index.htm | https://www.sec.gov/Archives/edgar/data/888491/000088849125000006/ohi-20241231x10k.htm | null | 2026-08-02T22:32:30 | yCAJcI9WPEgB7Jgu4 | t1OU8ZW9gS4Pwid9U | null |
0001474098 | Pebblebrook Hotel Trust | PEB | NYSE | 6798 | Real Estate Investment Trusts | MD | 1231 | operating | 0001474098-26-000015 | 10-K | 2026-02-25T00:00:00 | 2025-12-31T00:00:00 | 2026-02-25T16:08:44.000Z | null | 001-34571 | 14,692,159 | true | peb-20251231.htm | 10-K | https://www.sec.gov/Archives/edgar/data/1474098/000147409826000015/0001474098-26-000015-index.htm | https://www.sec.gov/Archives/edgar/data/1474098/000147409826000015/peb-20251231.htm | null | 2026-08-02T22:32:30 | yCAJcI9WPEgB7Jgu4 | t1OU8ZW9gS4Pwid9U | null |
0001474098 | Pebblebrook Hotel Trust | PEB | NYSE | 6798 | Real Estate Investment Trusts | MD | 1231 | operating | 0001474098-25-000039 | 10-K | 2025-02-26T00:00:00 | 2024-12-31T00:00:00 | 2025-02-26T16:10:17.000Z | null | 001-34571 | 14,080,255 | true | peb-20241231.htm | 10-K | https://www.sec.gov/Archives/edgar/data/1474098/000147409825000039/0001474098-25-000039-index.htm | https://www.sec.gov/Archives/edgar/data/1474098/000147409825000039/peb-20241231.htm | null | 2026-08-02T22:32:30 | yCAJcI9WPEgB7Jgu4 | t1OU8ZW9gS4Pwid9U | null |
0002081628 | Rithm Perpetual Life Residential Trust | null | null | 6798 | Real Estate Investment Trusts | MD | 1231 | operating | 0001628280-26-015484 | 10-K | 2026-03-06T00:00:00 | 2025-12-31T00:00:00 | 2026-03-06T14:37:13.000Z | null | 000-56783 | 6,546,526 | true | rhome-20251231.htm | 10-K | https://www.sec.gov/Archives/edgar/data/2081628/000162828026015484/0001628280-26-015484-index.htm | https://www.sec.gov/Archives/edgar/data/2081628/000162828026015484/rhome-20251231.htm | null | 2026-08-02T22:32:31 | yCAJcI9WPEgB7Jgu4 | t1OU8ZW9gS4Pwid9U | null |
0001511337 | RLJ Lodging Trust | RLJ | NYSE | 6798 | Real Estate Investment Trusts | MD | 1231 | operating | 0001511337-26-000007 | 10-K | 2026-02-27T00:00:00 | 2025-12-31T00:00:00 | 2026-02-27T21:49:02.000Z | null | 001-35169 | 16,501,653 | true | rlj-20251231.htm | 10-K | https://www.sec.gov/Archives/edgar/data/1511337/000151133726000007/0001511337-26-000007-index.htm | https://www.sec.gov/Archives/edgar/data/1511337/000151133726000007/rlj-20251231.htm | null | 2026-08-02T22:32:31 | yCAJcI9WPEgB7Jgu4 | t1OU8ZW9gS4Pwid9U | null |
0001511337 | RLJ Lodging Trust | RLJ | NYSE | 6798 | Real Estate Investment Trusts | MD | 1231 | operating | 0001511337-25-000007 | 10-K | 2025-02-26T00:00:00 | 2024-12-31T00:00:00 | 2025-02-26T20:07:40.000Z | null | 001-35169 | 16,533,015 | true | rlj-20241231.htm | 10-K | https://www.sec.gov/Archives/edgar/data/1511337/000151133725000007/0001511337-25-000007-index.htm | https://www.sec.gov/Archives/edgar/data/1511337/000151133725000007/rlj-20241231.htm | null | 2026-08-02T22:32:31 | yCAJcI9WPEgB7Jgu4 | t1OU8ZW9gS4Pwid9U | null |
0000907254 | SAUL CENTERS, INC. | BFS | NYSE | 6798 | Real Estate Investment Trusts | MD | 1231 | operating | 0000907254-26-000006 | 10-K | 2026-02-27T00:00:00 | 2025-12-31T00:00:00 | 2026-02-27T21:31:23.000Z | null | 001-12254 | 12,987,462 | true | bfs-20251231.htm | 10-K | https://www.sec.gov/Archives/edgar/data/907254/000090725426000006/0000907254-26-000006-index.htm | https://www.sec.gov/Archives/edgar/data/907254/000090725426000006/bfs-20251231.htm | null | 2026-08-02T22:32:31 | yCAJcI9WPEgB7Jgu4 | t1OU8ZW9gS4Pwid9U | null |
0000907254 | SAUL CENTERS, INC. | BFS | NYSE | 6798 | Real Estate Investment Trusts | MD | 1231 | operating | 0000907254-25-000022 | 10-K | 2025-02-28T00:00:00 | 2024-12-31T00:00:00 | 2025-02-28T22:27:36.000Z | null | 001-12254 | 15,392,745 | true | bfs-20241231.htm | 10-K | https://www.sec.gov/Archives/edgar/data/907254/000090725425000022/0000907254-25-000022-index.htm | https://www.sec.gov/Archives/edgar/data/907254/000090725425000022/bfs-20241231.htm | null | 2026-08-02T22:32:31 | yCAJcI9WPEgB7Jgu4 | t1OU8ZW9gS4Pwid9U | null |
0000019617 | JPMORGAN CHASE & CO | JPM | NYSE | 6021 | National Commercial Banks | DE | 1231 | operating | 0001628280-26-029344 | 10-Q | 2026-05-01T00:00:00 | 2026-03-31T00:00:00 | 2026-05-01T20:18:43.000Z | null | 001-05805 | 43,281,203 | true | jpm-20260331.htm | 10-Q | https://www.sec.gov/Archives/edgar/data/19617/000162828026029344/0001628280-26-029344-index.htm | https://www.sec.gov/Archives/edgar/data/19617/000162828026029344/jpm-20260331.htm | null | 2026-08-02T22:32:30 | wUxxfNY9VCk52xIb9 | RAFWFonyZ6yPvaS7l | {
"revenue": 182447000000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 57048000000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 4424900000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 4062462000000,
"totalLiabilitiesF... |
0000019617 | JPMORGAN CHASE & CO | JPM | NYSE | 6021 | National Commercial Banks | DE | 1231 | operating | 0001628280-26-008131 | 10-K | 2026-02-13T00:00:00 | 2025-12-31T00:00:00 | 2026-02-13T21:20:00.000Z | null | 001-05805 | 64,896,112 | true | jpm-20251231.htm | 10-K | https://www.sec.gov/Archives/edgar/data/19617/000162828026008131/0001628280-26-008131-index.htm | https://www.sec.gov/Archives/edgar/data/19617/000162828026008131/jpm-20251231.htm | null | 2026-08-02T22:32:30 | wUxxfNY9VCk52xIb9 | RAFWFonyZ6yPvaS7l | {
"revenue": 182447000000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 57048000000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 4424900000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 4062462000000,
"totalLiabilitiesF... |
0000019617 | JPMORGAN CHASE & CO | JPM | NYSE | 6021 | National Commercial Banks | DE | 1231 | operating | 0001628280-25-048859 | 10-Q | 2025-11-04T00:00:00 | 2025-09-30T00:00:00 | 2025-11-04T21:18:08.000Z | null | 001-05805 | 97,853,440 | true | jpm-20250930.htm | 10-Q | https://www.sec.gov/Archives/edgar/data/19617/000162828025048859/0001628280-25-048859-index.htm | https://www.sec.gov/Archives/edgar/data/19617/000162828025048859/jpm-20250930.htm | null | 2026-08-02T22:32:30 | wUxxfNY9VCk52xIb9 | RAFWFonyZ6yPvaS7l | {
"revenue": 182447000000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 57048000000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 4424900000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 4062462000000,
"totalLiabilitiesF... |
0000019617 | JPMORGAN CHASE & CO | JPM | NYSE | 6021 | National Commercial Banks | DE | 1231 | operating | 0000019617-25-000615 | 10-Q | 2025-08-05T00:00:00 | 2025-06-30T00:00:00 | 2025-08-05T20:18:22.000Z | null | 001-05805 | 50,321,066 | true | jpm-20250630.htm | 10-Q | https://www.sec.gov/Archives/edgar/data/19617/000001961725000615/0000019617-25-000615-index.htm | https://www.sec.gov/Archives/edgar/data/19617/000001961725000615/jpm-20250630.htm | null | 2026-08-02T22:32:30 | wUxxfNY9VCk52xIb9 | RAFWFonyZ6yPvaS7l | {
"revenue": 182447000000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 57048000000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 4424900000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 4062462000000,
"totalLiabilitiesF... |
0000070858 | BANK OF AMERICA CORP /DE/ | BAC | NYSE | 6021 | National Commercial Banks | DE | 1231 | operating | 0000070858-26-000394 | 10-Q | 2026-07-31T00:00:00 | 2026-06-30T00:00:00 | 2026-07-31T20:44:20.000Z | null | 001-06523 | 48,766,352 | true | bac-20260630.htm | 10-Q | https://www.sec.gov/Archives/edgar/data/70858/000007085826000394/0000070858-26-000394-index.htm | https://www.sec.gov/Archives/edgar/data/70858/000007085826000394/bac-20260630.htm | null | 2026-08-02T22:32:32 | wUxxfNY9VCk52xIb9 | RAFWFonyZ6yPvaS7l | {
"revenue": 113097000000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 30509000000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 3411738000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 3108495000000,
"totalLiabilitiesF... |
0000070858 | BANK OF AMERICA CORP /DE/ | BAC | NYSE | 6021 | National Commercial Banks | DE | 1231 | operating | 0000070858-26-000249 | 10-Q | 2026-05-01T00:00:00 | 2026-03-31T00:00:00 | 2026-05-01T20:39:01.000Z | null | 001-06523 | 43,186,026 | true | bac-20260331.htm | 10-Q | https://www.sec.gov/Archives/edgar/data/70858/000007085826000249/0000070858-26-000249-index.htm | https://www.sec.gov/Archives/edgar/data/70858/000007085826000249/bac-20260331.htm | null | 2026-08-02T22:32:32 | wUxxfNY9VCk52xIb9 | RAFWFonyZ6yPvaS7l | {
"revenue": 113097000000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 30509000000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 3411738000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 3108495000000,
"totalLiabilitiesF... |
0000070858 | BANK OF AMERICA CORP /DE/ | BAC | NYSE | 6021 | National Commercial Banks | DE | 1231 | operating | 0000070858-26-000157 | 10-K | 2026-02-25T00:00:00 | 2025-12-31T00:00:00 | 2026-02-25T22:01:44.000Z | null | 001-06523 | 62,237,235 | true | bac-20251231.htm | 10-K | https://www.sec.gov/Archives/edgar/data/70858/000007085826000157/0000070858-26-000157-index.htm | https://www.sec.gov/Archives/edgar/data/70858/000007085826000157/bac-20251231.htm | null | 2026-08-02T22:32:32 | wUxxfNY9VCk52xIb9 | RAFWFonyZ6yPvaS7l | {
"revenue": 113097000000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 30509000000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 3411738000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 3108495000000,
"totalLiabilitiesF... |
0000070858 | BANK OF AMERICA CORP /DE/ | BAC | NYSE | 6021 | National Commercial Banks | DE | 1231 | operating | 0000070858-25-000405 | 10-Q | 2025-10-31T00:00:00 | 2025-09-30T00:00:00 | 2025-10-31T20:36:23.000Z | null | 001-06523 | 48,685,742 | true | bac-20250930.htm | 10-Q | https://www.sec.gov/Archives/edgar/data/70858/000007085825000405/0000070858-25-000405-index.htm | https://www.sec.gov/Archives/edgar/data/70858/000007085825000405/bac-20250930.htm | null | 2026-08-02T22:32:32 | wUxxfNY9VCk52xIb9 | RAFWFonyZ6yPvaS7l | {
"revenue": 113097000000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 30509000000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 3411738000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 3108495000000,
"totalLiabilitiesF... |
0000072971 | WELLS FARGO & COMPANY/MN | WFC | NYSE | 6021 | National Commercial Banks | DE | 1231 | operating | 0000072971-26-000302 | 10-Q | 2026-07-28T00:00:00 | 2026-06-30T00:00:00 | 2026-07-28T20:46:31.000Z | null | 001-02979 | 48,442,178 | true | wfc-20260630.htm | FORM 10-Q | https://www.sec.gov/Archives/edgar/data/72971/000007297126000302/0000072971-26-000302-index.htm | https://www.sec.gov/Archives/edgar/data/72971/000007297126000302/wfc-20260630.htm | null | 2026-08-02T22:32:33 | wUxxfNY9VCk52xIb9 | RAFWFonyZ6yPvaS7l | {
"revenue": 85063000000,
"revenueFiscalYear": 2019,
"revenueForm": "10-K"
} |
0000072971 | WELLS FARGO & COMPANY/MN | WFC | NYSE | 6021 | National Commercial Banks | DE | 1231 | operating | 0000072971-26-000217 | 10-Q | 2026-04-29T00:00:00 | 2026-03-31T00:00:00 | 2026-04-29T21:05:34.000Z | null | 001-02979 | 43,267,948 | true | wfc-20260331.htm | FORM 10-Q | https://www.sec.gov/Archives/edgar/data/72971/000007297126000217/0000072971-26-000217-index.htm | https://www.sec.gov/Archives/edgar/data/72971/000007297126000217/wfc-20260331.htm | null | 2026-08-02T22:32:33 | wUxxfNY9VCk52xIb9 | RAFWFonyZ6yPvaS7l | {
"revenue": 85063000000,
"revenueFiscalYear": 2019,
"revenueForm": "10-K"
} |
0000072971 | WELLS FARGO & COMPANY/MN | WFC | NYSE | 6021 | National Commercial Banks | DE | 1231 | operating | 0000072971-26-000133 | 10-K | 2026-02-24T00:00:00 | 2025-12-31T00:00:00 | 2026-02-24T21:46:31.000Z | null | 001-02979 | 57,600,360 | true | wfc-20251231_d2.htm | FORM 10-K | https://www.sec.gov/Archives/edgar/data/72971/000007297126000133/0000072971-26-000133-index.htm | https://www.sec.gov/Archives/edgar/data/72971/000007297126000133/wfc-20251231_d2.htm | null | 2026-08-02T22:32:33 | wUxxfNY9VCk52xIb9 | RAFWFonyZ6yPvaS7l | {
"revenue": 85063000000,
"revenueFiscalYear": 2019,
"revenueForm": "10-K"
} |
0000072971 | WELLS FARGO & COMPANY/MN | WFC | NYSE | 6021 | National Commercial Banks | DE | 1231 | operating | 0000072971-25-000253 | 10-Q | 2025-10-31T00:00:00 | 2025-09-30T00:00:00 | 2025-10-31T20:23:21.000Z | null | 001-02979 | 49,298,420 | true | wfc-20250930.htm | FORM 10-Q | https://www.sec.gov/Archives/edgar/data/72971/000007297125000253/0000072971-25-000253-index.htm | https://www.sec.gov/Archives/edgar/data/72971/000007297125000253/wfc-20250930.htm | null | 2026-08-02T22:32:33 | wUxxfNY9VCk52xIb9 | RAFWFonyZ6yPvaS7l | {
"revenue": 85063000000,
"revenueFiscalYear": 2019,
"revenueForm": "10-K"
} |
0000072971 | WELLS FARGO & COMPANY/MN | WFC | NYSE | 6021 | National Commercial Banks | DE | 1231 | operating | 0000072971-25-000201 | 10-Q | 2025-08-05T00:00:00 | 2025-06-30T00:00:00 | 2025-08-05T13:28:49.000Z | null | 001-02979 | 50,084,365 | true | wfc-20250630.htm | FORM 10-Q | https://www.sec.gov/Archives/edgar/data/72971/000007297125000201/0000072971-25-000201-index.htm | https://www.sec.gov/Archives/edgar/data/72971/000007297125000201/wfc-20250630.htm | null | 2026-08-02T22:32:33 | wUxxfNY9VCk52xIb9 | RAFWFonyZ6yPvaS7l | {
"revenue": 85063000000,
"revenueFiscalYear": 2019,
"revenueForm": "10-K"
} |
0000072971 | WELLS FARGO & COMPANY/MN | WFC | NYSE | 6021 | National Commercial Banks | DE | 1231 | operating | 0000072971-25-000129 | 10-Q | 2025-04-29T00:00:00 | 2025-03-31T00:00:00 | 2025-04-29T20:44:59.000Z | null | 001-02979 | 43,051,549 | true | wfc-20250331.htm | FORM 10-Q | https://www.sec.gov/Archives/edgar/data/72971/000007297125000129/0000072971-25-000129-index.htm | https://www.sec.gov/Archives/edgar/data/72971/000007297125000129/wfc-20250331.htm | null | 2026-08-02T22:32:33 | wUxxfNY9VCk52xIb9 | RAFWFonyZ6yPvaS7l | {
"revenue": 85063000000,
"revenueFiscalYear": 2019,
"revenueForm": "10-K"
} |
0000831001 | CITIGROUP INC | C | NYSE | 6021 | National Commercial Banks | DE | 1231 | operating | 0000831001-26-000019 | 10-Q | 2026-05-07T00:00:00 | 2026-03-31T00:00:00 | 2026-05-07T20:50:22.000Z | null | 001-09924 | 51,716,184 | true | c-20260331.htm | 10-Q | https://www.sec.gov/Archives/edgar/data/831001/000083100126000019/0000831001-26-000019-index.htm | https://www.sec.gov/Archives/edgar/data/831001/000083100126000019/c-20260331.htm | null | 2026-08-02T22:32:35 | wUxxfNY9VCk52xIb9 | RAFWFonyZ6yPvaS7l | {
"revenue": 85225000000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 14306000000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 2657202000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 2443380000000,
"totalLiabilitiesFi... |
0000831001 | CITIGROUP INC | C | NYSE | 6021 | National Commercial Banks | DE | 1231 | operating | 0000831001-26-000011 | 10-K | 2026-02-20T00:00:00 | 2025-12-31T00:00:00 | 2026-02-20T22:06:54.000Z | null | 001-09924 | 80,991,821 | true | c-20251231.htm | 10-K | https://www.sec.gov/Archives/edgar/data/831001/000083100126000011/0000831001-26-000011-index.htm | https://www.sec.gov/Archives/edgar/data/831001/000083100126000011/c-20251231.htm | null | 2026-08-02T22:32:35 | wUxxfNY9VCk52xIb9 | RAFWFonyZ6yPvaS7l | {
"revenue": 85225000000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 14306000000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 2657202000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 2443380000000,
"totalLiabilitiesFi... |
0000831001 | CITIGROUP INC | C | NYSE | 6021 | National Commercial Banks | DE | 1231 | operating | 0000831001-25-000154 | 10-Q | 2025-11-06T00:00:00 | 2025-09-30T00:00:00 | 2025-11-06T21:55:48.000Z | null | 001-09924 | 64,202,961 | true | c-20250930.htm | 10-Q | https://www.sec.gov/Archives/edgar/data/831001/000083100125000154/0000831001-25-000154-index.htm | https://www.sec.gov/Archives/edgar/data/831001/000083100125000154/c-20250930.htm | null | 2026-08-02T22:32:35 | wUxxfNY9VCk52xIb9 | RAFWFonyZ6yPvaS7l | {
"revenue": 85225000000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 14306000000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 2657202000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 2443380000000,
"totalLiabilitiesFi... |
0000831001 | CITIGROUP INC | C | NYSE | 6021 | National Commercial Banks | DE | 1231 | operating | 0000831001-25-000131 | 10-Q | 2025-08-06T00:00:00 | 2025-06-30T00:00:00 | 2025-08-06T20:52:00.000Z | null | 001-09924 | 68,670,699 | true | c-20250630.htm | 10-Q | https://www.sec.gov/Archives/edgar/data/831001/000083100125000131/0000831001-25-000131-index.htm | https://www.sec.gov/Archives/edgar/data/831001/000083100125000131/c-20250630.htm | null | 2026-08-02T22:32:35 | wUxxfNY9VCk52xIb9 | RAFWFonyZ6yPvaS7l | {
"revenue": 85225000000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 14306000000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 2657202000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 2443380000000,
"totalLiabilitiesFi... |
0000886982 | GOLDMAN SACHS GROUP INC | GS | NYSE | 6211 | Security Brokers, Dealers & Flotation Companies | DE | 1231 | operating | 0000886982-26-000118 | 10-Q | 2026-05-01T00:00:00 | 2026-03-31T00:00:00 | 2026-05-01T20:14:24.000Z | null | 001-14965 | 38,676,891 | true | gs-20260331.htm | 10-Q | https://www.sec.gov/Archives/edgar/data/886982/000088698226000118/0000886982-26-000118-index.htm | https://www.sec.gov/Archives/edgar/data/886982/000088698226000118/gs-20260331.htm | null | 2026-08-02T22:32:36 | wUxxfNY9VCk52xIb9 | RAFWFonyZ6yPvaS7l | {
"netIncome": 17176000000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 1809320000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 1684348000000,
"totalLiabilitiesFiscalYear": 2025,
"totalLiabilitiesForm": "10-K",
"stockholdersEquity": 12497... |
0000886982 | GOLDMAN SACHS GROUP INC | GS | NYSE | 6211 | Security Brokers, Dealers & Flotation Companies | DE | 1231 | operating | 0000886982-26-000091 | 10-K | 2026-02-25T00:00:00 | 2025-12-31T00:00:00 | 2026-02-25T22:22:27.000Z | null | 001-14965 | 49,399,989 | true | gs-20251231.htm | 10-K | https://www.sec.gov/Archives/edgar/data/886982/000088698226000091/0000886982-26-000091-index.htm | https://www.sec.gov/Archives/edgar/data/886982/000088698226000091/gs-20251231.htm | null | 2026-08-02T22:32:36 | wUxxfNY9VCk52xIb9 | RAFWFonyZ6yPvaS7l | {
"netIncome": 17176000000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 1809320000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 1684348000000,
"totalLiabilitiesFiscalYear": 2025,
"totalLiabilitiesForm": "10-K",
"stockholdersEquity": 12497... |
0000886982 | GOLDMAN SACHS GROUP INC | GS | NYSE | 6211 | Security Brokers, Dealers & Flotation Companies | DE | 1231 | operating | 0000886982-25-001411 | 10-Q | 2025-10-31T00:00:00 | 2025-09-30T00:00:00 | 2025-10-31T20:17:56.000Z | null | 001-14965 | 44,080,458 | true | gs-20250930.htm | 10-Q | https://www.sec.gov/Archives/edgar/data/886982/000088698225001411/0000886982-25-001411-index.htm | https://www.sec.gov/Archives/edgar/data/886982/000088698225001411/gs-20250930.htm | null | 2026-08-02T22:32:36 | wUxxfNY9VCk52xIb9 | RAFWFonyZ6yPvaS7l | {
"netIncome": 17176000000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 1809320000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 1684348000000,
"totalLiabilitiesFiscalYear": 2025,
"totalLiabilitiesForm": "10-K",
"stockholdersEquity": 12497... |
0000886982 | GOLDMAN SACHS GROUP INC | GS | NYSE | 6211 | Security Brokers, Dealers & Flotation Companies | DE | 1231 | operating | 0000886982-25-000022 | 10-Q | 2025-08-01T00:00:00 | 2025-06-30T00:00:00 | 2025-08-01T20:40:51.000Z | null | 001-14965 | 45,092,191 | true | gs-20250630.htm | 10-Q | https://www.sec.gov/Archives/edgar/data/886982/000088698225000022/0000886982-25-000022-index.htm | https://www.sec.gov/Archives/edgar/data/886982/000088698225000022/gs-20250630.htm | null | 2026-08-02T22:32:36 | wUxxfNY9VCk52xIb9 | RAFWFonyZ6yPvaS7l | {
"netIncome": 17176000000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 1809320000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 1684348000000,
"totalLiabilitiesFiscalYear": 2025,
"totalLiabilitiesForm": "10-K",
"stockholdersEquity": 12497... |
0000895421 | MORGAN STANLEY | MS | NYSE | 6211 | Security Brokers, Dealers & Flotation Companies | DE | 1231 | operating | 0000895421-26-000121 | 10-Q | 2026-05-05T00:00:00 | 2026-03-31T00:00:00 | 2026-05-05T20:15:42.000Z | null | 001-11758 | 32,694,594 | true | ms-20260331.htm | 10-Q | https://www.sec.gov/Archives/edgar/data/895421/000089542126000121/0000895421-26-000121-index.htm | https://www.sec.gov/Archives/edgar/data/895421/000089542126000121/ms-20260331.htm | null | 2026-08-02T22:32:39 | wUxxfNY9VCk52xIb9 | RAFWFonyZ6yPvaS7l | {
"revenue": 5910000000,
"revenueFiscalYear": 2018,
"revenueForm": "10-Q",
"netIncome": 16861000000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 1420270000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 1307618000000,
"totalLiabilitiesFis... |
0000895421 | MORGAN STANLEY | MS | NYSE | 6211 | Security Brokers, Dealers & Flotation Companies | DE | 1231 | operating | 0000895421-26-000086 | 10-K | 2026-02-19T00:00:00 | 2025-12-31T00:00:00 | 2026-02-19T21:42:18.000Z | null | 001-11758 | 47,397,260 | true | ms-20251231.htm | 10-K | https://www.sec.gov/Archives/edgar/data/895421/000089542126000086/0000895421-26-000086-index.htm | https://www.sec.gov/Archives/edgar/data/895421/000089542126000086/ms-20251231.htm | null | 2026-08-02T22:32:39 | wUxxfNY9VCk52xIb9 | RAFWFonyZ6yPvaS7l | {
"revenue": 5910000000,
"revenueFiscalYear": 2018,
"revenueForm": "10-Q",
"netIncome": 16861000000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 1420270000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 1307618000000,
"totalLiabilitiesFis... |
0000895421 | MORGAN STANLEY | MS | NYSE | 6211 | Security Brokers, Dealers & Flotation Companies | DE | 1231 | operating | 0000895421-25-000539 | 10-Q | 2025-11-03T00:00:00 | 2025-09-30T00:00:00 | 2025-11-03T21:09:09.000Z | null | 001-11758 | 37,098,650 | true | ms-20250930.htm | 10-Q | https://www.sec.gov/Archives/edgar/data/895421/000089542125000539/0000895421-25-000539-index.htm | https://www.sec.gov/Archives/edgar/data/895421/000089542125000539/ms-20250930.htm | null | 2026-08-02T22:32:39 | wUxxfNY9VCk52xIb9 | RAFWFonyZ6yPvaS7l | {
"revenue": 5910000000,
"revenueFiscalYear": 2018,
"revenueForm": "10-Q",
"netIncome": 16861000000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 1420270000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 1307618000000,
"totalLiabilitiesFis... |
0000895421 | MORGAN STANLEY | MS | NYSE | 6211 | Security Brokers, Dealers & Flotation Companies | DE | 1231 | operating | 0000895421-25-000440 | 10-Q | 2025-08-04T00:00:00 | 2025-06-30T00:00:00 | 2025-08-04T20:30:56.000Z | null | 001-11758 | 36,970,935 | true | ms-20250630.htm | 10-Q | https://www.sec.gov/Archives/edgar/data/895421/000089542125000440/0000895421-25-000440-index.htm | https://www.sec.gov/Archives/edgar/data/895421/000089542125000440/ms-20250630.htm | null | 2026-08-02T22:32:39 | wUxxfNY9VCk52xIb9 | RAFWFonyZ6yPvaS7l | {
"revenue": 5910000000,
"revenueFiscalYear": 2018,
"revenueForm": "10-Q",
"netIncome": 16861000000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 1420270000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 1307618000000,
"totalLiabilitiesFis... |
0001682852 | Moderna, Inc. | MRNA | Nasdaq | 2836 | Biological Products, (No Diagnostic Substances) | DE | 1231 | operating | 0001682852-26-000150 | 10-Q | 2026-07-31T00:00:00 | 2026-06-30T00:00:00 | 2026-07-31T20:17:41.000Z | null | 001-38753 | 10,016,779 | true | mrna-20260630.htm | 10-Q | https://www.sec.gov/Archives/edgar/data/1682852/000168285226000150/0001682852-26-000150-index.htm | https://www.sec.gov/Archives/edgar/data/1682852/000168285226000150/mrna-20260630.htm | null | 2026-08-02T22:32:29 | q2WFUM3awWhPVWpQ3 | u1Oo7iedJLPoghB2j | {
"revenue": 1944000000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": -2822000000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 12338000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 3688000000,
"totalLiabilitiesFiscalYe... |
0001682852 | Moderna, Inc. | MRNA | Nasdaq | 2836 | Biological Products, (No Diagnostic Substances) | DE | 1231 | operating | 0001682852-26-000060 | 10-Q | 2026-05-01T00:00:00 | 2026-03-31T00:00:00 | 2026-05-01T20:10:14.000Z | null | 001-38753 | 8,866,127 | true | mrna-20260331.htm | 10-Q | https://www.sec.gov/Archives/edgar/data/1682852/000168285226000060/0001682852-26-000060-index.htm | https://www.sec.gov/Archives/edgar/data/1682852/000168285226000060/mrna-20260331.htm | null | 2026-08-02T22:32:29 | q2WFUM3awWhPVWpQ3 | u1Oo7iedJLPoghB2j | {
"revenue": 1944000000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": -2822000000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 12338000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 3688000000,
"totalLiabilitiesFiscalYe... |
0001682852 | Moderna, Inc. | MRNA | Nasdaq | 2836 | Biological Products, (No Diagnostic Substances) | DE | 1231 | operating | 0001682852-26-000033 | 10-K | 2026-02-20T00:00:00 | 2025-12-31T00:00:00 | 2026-02-20T21:02:04.000Z | null | 001-38753 | 15,777,938 | true | mrna-20251231.htm | 10-K | https://www.sec.gov/Archives/edgar/data/1682852/000168285226000033/0001682852-26-000033-index.htm | https://www.sec.gov/Archives/edgar/data/1682852/000168285226000033/mrna-20251231.htm | null | 2026-08-02T22:32:29 | q2WFUM3awWhPVWpQ3 | u1Oo7iedJLPoghB2j | {
"revenue": 1944000000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": -2822000000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 12338000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 3688000000,
"totalLiabilitiesFiscalYe... |
0001682852 | Moderna, Inc. | MRNA | Nasdaq | 2836 | Biological Products, (No Diagnostic Substances) | DE | 1231 | operating | 0001682852-25-000075 | 10-Q | 2025-11-06T00:00:00 | 2025-09-30T00:00:00 | 2025-11-06T21:05:25.000Z | null | 001-38753 | 9,499,573 | true | mrna-20250930.htm | 10-Q | https://www.sec.gov/Archives/edgar/data/1682852/000168285225000075/0001682852-25-000075-index.htm | https://www.sec.gov/Archives/edgar/data/1682852/000168285225000075/mrna-20250930.htm | null | 2026-08-02T22:32:29 | q2WFUM3awWhPVWpQ3 | u1Oo7iedJLPoghB2j | {
"revenue": 1944000000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": -2822000000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 12338000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 3688000000,
"totalLiabilitiesFiscalYe... |
0001682852 | Moderna, Inc. | MRNA | Nasdaq | 2836 | Biological Products, (No Diagnostic Substances) | DE | 1231 | operating | 0001682852-25-000044 | 10-Q | 2025-08-01T00:00:00 | 2025-06-30T00:00:00 | 2025-08-01T20:03:34.000Z | null | 001-38753 | 9,144,434 | true | mrna-20250630.htm | 10-Q | https://www.sec.gov/Archives/edgar/data/1682852/000168285225000044/0001682852-25-000044-index.htm | https://www.sec.gov/Archives/edgar/data/1682852/000168285225000044/mrna-20250630.htm | null | 2026-08-02T22:32:29 | q2WFUM3awWhPVWpQ3 | u1Oo7iedJLPoghB2j | {
"revenue": 1944000000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": -2822000000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 12338000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 3688000000,
"totalLiabilitiesFiscalYe... |
0001682852 | Moderna, Inc. | MRNA | Nasdaq | 2836 | Biological Products, (No Diagnostic Substances) | DE | 1231 | operating | 0001682852-25-000034 | 10-Q | 2025-05-01T00:00:00 | 2025-03-31T00:00:00 | 2025-05-01T20:02:14.000Z | null | 001-38753 | 8,852,819 | true | mrna-20250331.htm | 10-Q | https://www.sec.gov/Archives/edgar/data/1682852/000168285225000034/0001682852-25-000034-index.htm | https://www.sec.gov/Archives/edgar/data/1682852/000168285225000034/mrna-20250331.htm | null | 2026-08-02T22:32:29 | q2WFUM3awWhPVWpQ3 | u1Oo7iedJLPoghB2j | {
"revenue": 1944000000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": -2822000000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 12338000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 3688000000,
"totalLiabilitiesFiscalYe... |
0001682852 | Moderna, Inc. | MRNA | Nasdaq | 2836 | Biological Products, (No Diagnostic Substances) | DE | 1231 | operating | 0001682852-25-000022 | 10-K | 2025-02-21T00:00:00 | 2024-12-31T00:00:00 | 2025-02-21T12:11:05.000Z | null | 001-38753 | 17,646,681 | true | mrna-20241231.htm | 10-K | https://www.sec.gov/Archives/edgar/data/1682852/000168285225000022/0001682852-25-000022-index.htm | https://www.sec.gov/Archives/edgar/data/1682852/000168285225000022/mrna-20241231.htm | null | 2026-08-02T22:32:29 | q2WFUM3awWhPVWpQ3 | u1Oo7iedJLPoghB2j | {
"revenue": 1944000000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": -2822000000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 12338000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 3688000000,
"totalLiabilitiesFiscalYe... |
0001682852 | Moderna, Inc. | MRNA | Nasdaq | 2836 | Biological Products, (No Diagnostic Substances) | DE | 1231 | operating | 0001682852-24-000060 | 10-Q | 2024-11-07T00:00:00 | 2024-09-30T00:00:00 | 2024-11-07T21:03:09.000Z | null | 001-38753 | 9,380,308 | true | mrna-20240930.htm | 10-Q | https://www.sec.gov/Archives/edgar/data/1682852/000168285224000060/0001682852-24-000060-index.htm | https://www.sec.gov/Archives/edgar/data/1682852/000168285224000060/mrna-20240930.htm | null | 2026-08-02T22:32:29 | q2WFUM3awWhPVWpQ3 | u1Oo7iedJLPoghB2j | {
"revenue": 1944000000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": -2822000000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 12338000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 3688000000,
"totalLiabilitiesFiscalYe... |
0001682852 | Moderna, Inc. | MRNA | Nasdaq | 2836 | Biological Products, (No Diagnostic Substances) | DE | 1231 | operating | 0001682852-24-000046 | 10-Q | 2024-08-01T00:00:00 | 2024-06-30T00:00:00 | 2024-08-01T20:02:28.000Z | null | 001-38753 | 9,871,388 | true | mrna-20240630.htm | 10-Q | https://www.sec.gov/Archives/edgar/data/1682852/000168285224000046/0001682852-24-000046-index.htm | https://www.sec.gov/Archives/edgar/data/1682852/000168285224000046/mrna-20240630.htm | null | 2026-08-02T22:32:29 | q2WFUM3awWhPVWpQ3 | u1Oo7iedJLPoghB2j | {
"revenue": 1944000000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": -2822000000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 12338000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 3688000000,
"totalLiabilitiesFiscalYe... |
0001682852 | Moderna, Inc. | MRNA | Nasdaq | 2836 | Biological Products, (No Diagnostic Substances) | DE | 1231 | operating | 0001682852-24-000027 | 10-Q | 2024-05-02T00:00:00 | 2024-03-31T00:00:00 | 2024-05-02T20:03:11.000Z | null | 001-38753 | 8,776,524 | true | mrna-20240331.htm | 10-Q | https://www.sec.gov/Archives/edgar/data/1682852/000168285224000027/0001682852-24-000027-index.htm | https://www.sec.gov/Archives/edgar/data/1682852/000168285224000027/mrna-20240331.htm | null | 2026-08-02T22:32:29 | q2WFUM3awWhPVWpQ3 | u1Oo7iedJLPoghB2j | {
"revenue": 1944000000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": -2822000000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 12338000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 3688000000,
"totalLiabilitiesFiscalYe... |
0001682852 | Moderna, Inc. | MRNA | Nasdaq | 2836 | Biological Products, (No Diagnostic Substances) | DE | 1231 | operating | 0001682852-24-000015 | 10-K | 2024-02-23T00:00:00 | 2023-12-31T00:00:00 | 2024-02-23T21:03:10.000Z | null | 001-38753 | 16,566,414 | true | mrna-20231231.htm | 10-K | https://www.sec.gov/Archives/edgar/data/1682852/000168285224000015/0001682852-24-000015-index.htm | https://www.sec.gov/Archives/edgar/data/1682852/000168285224000015/mrna-20231231.htm | null | 2026-08-02T22:32:29 | q2WFUM3awWhPVWpQ3 | u1Oo7iedJLPoghB2j | {
"revenue": 1944000000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": -2822000000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 12338000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 3688000000,
"totalLiabilitiesFiscalYe... |
0001682852 | Moderna, Inc. | MRNA | Nasdaq | 2836 | Biological Products, (No Diagnostic Substances) | DE | 1231 | operating | 0001682852-23-000042 | 10-Q | 2023-11-03T00:00:00 | 2023-09-30T00:00:00 | 2023-11-03T20:02:21.000Z | null | 001-38753 | 10,883,546 | true | mrna-20230930.htm | 10-Q | https://www.sec.gov/Archives/edgar/data/1682852/000168285223000042/0001682852-23-000042-index.htm | https://www.sec.gov/Archives/edgar/data/1682852/000168285223000042/mrna-20230930.htm | null | 2026-08-02T22:32:29 | q2WFUM3awWhPVWpQ3 | u1Oo7iedJLPoghB2j | {
"revenue": 1944000000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": -2822000000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 12338000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 3688000000,
"totalLiabilitiesFiscalYe... |
0001682852 | Moderna, Inc. | MRNA | Nasdaq | 2836 | Biological Products, (No Diagnostic Substances) | DE | 1231 | operating | 0001682852-23-000027 | 10-Q | 2023-08-03T00:00:00 | 2023-06-30T00:00:00 | 2023-08-03T20:04:10.000Z | null | 001-38753 | 10,070,928 | true | mrna-20230630.htm | 10-Q | https://www.sec.gov/Archives/edgar/data/1682852/000168285223000027/0001682852-23-000027-index.htm | https://www.sec.gov/Archives/edgar/data/1682852/000168285223000027/mrna-20230630.htm | null | 2026-08-02T22:32:29 | q2WFUM3awWhPVWpQ3 | u1Oo7iedJLPoghB2j | {
"revenue": 1944000000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": -2822000000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 12338000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 3688000000,
"totalLiabilitiesFiscalYe... |
0001682852 | Moderna, Inc. | MRNA | Nasdaq | 2836 | Biological Products, (No Diagnostic Substances) | DE | 1231 | operating | 0001682852-23-000021 | 10-Q | 2023-05-04T00:00:00 | 2023-03-31T00:00:00 | 2023-05-04T20:03:31.000Z | null | 001-38753 | 10,109,151 | true | mrna-20230331.htm | 10-Q | https://www.sec.gov/Archives/edgar/data/1682852/000168285223000021/0001682852-23-000021-index.htm | https://www.sec.gov/Archives/edgar/data/1682852/000168285223000021/mrna-20230331.htm | null | 2026-08-02T22:32:29 | q2WFUM3awWhPVWpQ3 | u1Oo7iedJLPoghB2j | {
"revenue": 1944000000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": -2822000000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 12338000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 3688000000,
"totalLiabilitiesFiscalYe... |
0000872589 | REGENERON PHARMACEUTICALS, INC. | REGN | Nasdaq | 2834 | Pharmaceutical Preparations | NY | 1231 | operating | 0000872589-26-000025 | 10-Q | 2026-07-30T00:00:00 | 2026-06-30T00:00:00 | 2026-07-30T10:52:16.000Z | null | 000-19034 | 7,357,606 | true | regn-20260630.htm | 10-Q | https://www.sec.gov/Archives/edgar/data/872589/000087258926000025/0000872589-26-000025-index.htm | https://www.sec.gov/Archives/edgar/data/872589/000087258926000025/regn-20260630.htm | null | 2026-08-02T22:32:31 | q2WFUM3awWhPVWpQ3 | u1Oo7iedJLPoghB2j | {
"revenue": 14342900000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 4504900000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 40558700000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 9301800000,
"totalLiabilitiesFiscalYe... |
0000872589 | REGENERON PHARMACEUTICALS, INC. | REGN | Nasdaq | 2834 | Pharmaceutical Preparations | NY | 1231 | operating | 0000872589-26-000016 | 10-Q | 2026-04-29T00:00:00 | 2026-03-31T00:00:00 | 2026-04-29T10:54:54.000Z | null | 000-19034 | 6,434,158 | true | regn-20260331.htm | 10-Q | https://www.sec.gov/Archives/edgar/data/872589/000087258926000016/0000872589-26-000016-index.htm | https://www.sec.gov/Archives/edgar/data/872589/000087258926000016/regn-20260331.htm | null | 2026-08-02T22:32:31 | q2WFUM3awWhPVWpQ3 | u1Oo7iedJLPoghB2j | {
"revenue": 14342900000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 4504900000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 40558700000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 9301800000,
"totalLiabilitiesFiscalYe... |
0000872589 | REGENERON PHARMACEUTICALS, INC. | REGN | Nasdaq | 2834 | Pharmaceutical Preparations | NY | 1231 | operating | 0000872589-26-000008 | 10-K | 2026-02-04T00:00:00 | 2025-12-31T00:00:00 | 2026-02-04T14:08:38.000Z | null | 000-19034 | 13,847,011 | true | regn-20251231.htm | 10-K | https://www.sec.gov/Archives/edgar/data/872589/000087258926000008/0000872589-26-000008-index.htm | https://www.sec.gov/Archives/edgar/data/872589/000087258926000008/regn-20251231.htm | null | 2026-08-02T22:32:31 | q2WFUM3awWhPVWpQ3 | u1Oo7iedJLPoghB2j | {
"revenue": 14342900000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 4504900000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 40558700000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 9301800000,
"totalLiabilitiesFiscalYe... |
0000872589 | REGENERON PHARMACEUTICALS, INC. | REGN | Nasdaq | 2834 | Pharmaceutical Preparations | NY | 1231 | operating | 0000872589-25-000028 | 10-Q | 2025-10-28T00:00:00 | 2025-09-30T00:00:00 | 2025-10-28T10:56:36.000Z | null | 000-19034 | 8,177,590 | true | regn-20250930.htm | 10-Q | https://www.sec.gov/Archives/edgar/data/872589/000087258925000028/0000872589-25-000028-index.htm | https://www.sec.gov/Archives/edgar/data/872589/000087258925000028/regn-20250930.htm | null | 2026-08-02T22:32:31 | q2WFUM3awWhPVWpQ3 | u1Oo7iedJLPoghB2j | {
"revenue": 14342900000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 4504900000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 40558700000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 9301800000,
"totalLiabilitiesFiscalYe... |
0000872589 | REGENERON PHARMACEUTICALS, INC. | REGN | Nasdaq | 2834 | Pharmaceutical Preparations | NY | 1231 | operating | 0000872589-25-000019 | 10-Q | 2025-08-01T00:00:00 | 2025-06-30T00:00:00 | 2025-08-01T10:56:11.000Z | null | 000-19034 | 8,104,963 | true | regn-20250630.htm | 10-Q | https://www.sec.gov/Archives/edgar/data/872589/000087258925000019/0000872589-25-000019-index.htm | https://www.sec.gov/Archives/edgar/data/872589/000087258925000019/regn-20250630.htm | null | 2026-08-02T22:32:31 | q2WFUM3awWhPVWpQ3 | u1Oo7iedJLPoghB2j | {
"revenue": 14342900000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 4504900000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 40558700000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 9301800000,
"totalLiabilitiesFiscalYe... |
0000872589 | REGENERON PHARMACEUTICALS, INC. | REGN | Nasdaq | 2834 | Pharmaceutical Preparations | NY | 1231 | operating | 0001804220-25-000022 | 10-Q | 2025-04-29T00:00:00 | 2025-03-31T00:00:00 | 2025-04-29T10:51:48.000Z | null | 000-19034 | 6,932,326 | true | regn-20250331.htm | 10-Q | https://www.sec.gov/Archives/edgar/data/872589/000180422025000022/0001804220-25-000022-index.htm | https://www.sec.gov/Archives/edgar/data/872589/000180422025000022/regn-20250331.htm | null | 2026-08-02T22:32:31 | q2WFUM3awWhPVWpQ3 | u1Oo7iedJLPoghB2j | {
"revenue": 14342900000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 4504900000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 40558700000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 9301800000,
"totalLiabilitiesFiscalYe... |
0000872589 | REGENERON PHARMACEUTICALS, INC. | REGN | Nasdaq | 2834 | Pharmaceutical Preparations | NY | 1231 | operating | 0001804220-25-000011 | 10-K | 2025-02-05T00:00:00 | 2024-12-31T00:00:00 | 2025-02-05T14:18:14.000Z | null | 000-19034 | 14,398,005 | true | regn-20241231.htm | 10-K | https://www.sec.gov/Archives/edgar/data/872589/000180422025000011/0001804220-25-000011-index.htm | https://www.sec.gov/Archives/edgar/data/872589/000180422025000011/regn-20241231.htm | null | 2026-08-02T22:32:31 | q2WFUM3awWhPVWpQ3 | u1Oo7iedJLPoghB2j | {
"revenue": 14342900000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 4504900000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 40558700000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 9301800000,
"totalLiabilitiesFiscalYe... |
0000872589 | REGENERON PHARMACEUTICALS, INC. | REGN | Nasdaq | 2834 | Pharmaceutical Preparations | NY | 1231 | operating | 0001804220-24-000040 | 10-Q | 2024-10-31T00:00:00 | 2024-09-30T00:00:00 | 2024-10-31T11:16:48.000Z | null | 000-19034 | 8,075,157 | true | regn-20240930.htm | 10-Q | https://www.sec.gov/Archives/edgar/data/872589/000180422024000040/0001804220-24-000040-index.htm | https://www.sec.gov/Archives/edgar/data/872589/000180422024000040/regn-20240930.htm | null | 2026-08-02T22:32:31 | q2WFUM3awWhPVWpQ3 | u1Oo7iedJLPoghB2j | {
"revenue": 14342900000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 4504900000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 40558700000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 9301800000,
"totalLiabilitiesFiscalYe... |
0000872589 | REGENERON PHARMACEUTICALS, INC. | REGN | Nasdaq | 2834 | Pharmaceutical Preparations | NY | 1231 | operating | 0001804220-24-000028 | 10-Q | 2024-08-01T00:00:00 | 2024-06-30T00:00:00 | 2024-08-01T11:15:21.000Z | null | 000-19034 | 7,659,675 | true | regn-20240630.htm | 10-Q | https://www.sec.gov/Archives/edgar/data/872589/000180422024000028/0001804220-24-000028-index.htm | https://www.sec.gov/Archives/edgar/data/872589/000180422024000028/regn-20240630.htm | null | 2026-08-02T22:32:31 | q2WFUM3awWhPVWpQ3 | u1Oo7iedJLPoghB2j | {
"revenue": 14342900000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 4504900000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 40558700000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 9301800000,
"totalLiabilitiesFiscalYe... |
0000872589 | REGENERON PHARMACEUTICALS, INC. | REGN | Nasdaq | 2834 | Pharmaceutical Preparations | NY | 1231 | operating | 0001804220-24-000017 | 10-Q | 2024-05-02T00:00:00 | 2024-03-31T00:00:00 | 2024-05-02T11:13:11.000Z | null | 000-19034 | 6,963,259 | true | regn-20240331.htm | 10-Q | https://www.sec.gov/Archives/edgar/data/872589/000180422024000017/0001804220-24-000017-index.htm | https://www.sec.gov/Archives/edgar/data/872589/000180422024000017/regn-20240331.htm | null | 2026-08-02T22:32:31 | q2WFUM3awWhPVWpQ3 | u1Oo7iedJLPoghB2j | {
"revenue": 14342900000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 4504900000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 40558700000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 9301800000,
"totalLiabilitiesFiscalYe... |
0000872589 | REGENERON PHARMACEUTICALS, INC. | REGN | Nasdaq | 2834 | Pharmaceutical Preparations | NY | 1231 | operating | 0001804220-24-000009 | 10-K | 2024-02-05T00:00:00 | 2023-12-31T00:00:00 | 2024-02-05T14:16:15.000Z | null | 000-19034 | 15,192,037 | true | regn-20231231.htm | 10-K | https://www.sec.gov/Archives/edgar/data/872589/000180422024000009/0001804220-24-000009-index.htm | https://www.sec.gov/Archives/edgar/data/872589/000180422024000009/regn-20231231.htm | null | 2026-08-02T22:32:31 | q2WFUM3awWhPVWpQ3 | u1Oo7iedJLPoghB2j | {
"revenue": 14342900000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 4504900000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 40558700000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 9301800000,
"totalLiabilitiesFiscalYe... |
0000872589 | REGENERON PHARMACEUTICALS, INC. | REGN | Nasdaq | 2834 | Pharmaceutical Preparations | NY | 1231 | operating | 0001804220-23-000031 | 10-Q | 2023-11-02T00:00:00 | 2023-09-30T00:00:00 | 2023-11-02T11:22:07.000Z | null | 000-19034 | 9,125,448 | true | regn-20230930.htm | 10-Q | https://www.sec.gov/Archives/edgar/data/872589/000180422023000031/0001804220-23-000031-index.htm | https://www.sec.gov/Archives/edgar/data/872589/000180422023000031/regn-20230930.htm | null | 2026-08-02T22:32:31 | q2WFUM3awWhPVWpQ3 | u1Oo7iedJLPoghB2j | {
"revenue": 14342900000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 4504900000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 40558700000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 9301800000,
"totalLiabilitiesFiscalYe... |
0000872589 | REGENERON PHARMACEUTICALS, INC. | REGN | Nasdaq | 2834 | Pharmaceutical Preparations | NY | 1231 | operating | 0001804220-23-000023 | 10-Q | 2023-08-03T00:00:00 | 2023-06-30T00:00:00 | 2023-08-03T10:56:05.000Z | null | 000-19034 | 8,272,020 | true | regn-20230630.htm | 10-Q | https://www.sec.gov/Archives/edgar/data/872589/000180422023000023/0001804220-23-000023-index.htm | https://www.sec.gov/Archives/edgar/data/872589/000180422023000023/regn-20230630.htm | null | 2026-08-02T22:32:31 | q2WFUM3awWhPVWpQ3 | u1Oo7iedJLPoghB2j | {
"revenue": 14342900000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 4504900000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 40558700000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 9301800000,
"totalLiabilitiesFiscalYe... |
0000872589 | REGENERON PHARMACEUTICALS, INC. | REGN | Nasdaq | 2834 | Pharmaceutical Preparations | NY | 1231 | operating | 0001804220-23-000016 | 10-Q | 2023-05-04T00:00:00 | 2023-03-31T00:00:00 | 2023-05-04T11:14:54.000Z | null | 000-19034 | 7,151,159 | true | regn-20230331.htm | 10-Q | https://www.sec.gov/Archives/edgar/data/872589/000180422023000016/0001804220-23-000016-index.htm | https://www.sec.gov/Archives/edgar/data/872589/000180422023000016/regn-20230331.htm | null | 2026-08-02T22:32:31 | q2WFUM3awWhPVWpQ3 | u1Oo7iedJLPoghB2j | {
"revenue": 14342900000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 4504900000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 40558700000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 9301800000,
"totalLiabilitiesFiscalYe... |
0000875320 | VERTEX PHARMACEUTICALS INC / MA | VRTX | Nasdaq | 2834 | Pharmaceutical Preparations | MA | 1231 | operating | 0000875320-26-000173 | 10-Q | 2026-05-05T00:00:00 | 2026-03-31T00:00:00 | 2026-05-05T20:08:44.000Z | null | 000-19319 | 9,804,761 | true | vrtx-20260331.htm | 10-Q | https://www.sec.gov/Archives/edgar/data/875320/000087532026000173/0000875320-26-000173-index.htm | https://www.sec.gov/Archives/edgar/data/875320/000087532026000173/vrtx-20260331.htm | null | 2026-08-02T22:32:32 | q2WFUM3awWhPVWpQ3 | u1Oo7iedJLPoghB2j | {
"revenue": 12001300000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 3953200000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 25643000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 6977200000,
"totalLiabilitiesFiscalYe... |
0000875320 | VERTEX PHARMACEUTICALS INC / MA | VRTX | Nasdaq | 2834 | Pharmaceutical Preparations | MA | 1231 | operating | 0000875320-26-000056 | 10-K | 2026-02-13T00:00:00 | 2025-12-31T00:00:00 | 2026-02-13T21:20:09.000Z | null | 000-19319 | 25,238,016 | true | vrtx-20251231.htm | 10-K | https://www.sec.gov/Archives/edgar/data/875320/000087532026000056/0000875320-26-000056-index.htm | https://www.sec.gov/Archives/edgar/data/875320/000087532026000056/vrtx-20251231.htm | null | 2026-08-02T22:32:32 | q2WFUM3awWhPVWpQ3 | u1Oo7iedJLPoghB2j | {
"revenue": 12001300000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 3953200000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 25643000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 6977200000,
"totalLiabilitiesFiscalYe... |
0000875320 | VERTEX PHARMACEUTICALS INC / MA | VRTX | Nasdaq | 2834 | Pharmaceutical Preparations | MA | 1231 | operating | 0000875320-25-000232 | 10-Q | 2025-11-04T00:00:00 | 2025-09-30T00:00:00 | 2025-11-04T21:03:17.000Z | null | 000-19319 | 9,016,870 | true | vrtx-20250930.htm | 10-Q | https://www.sec.gov/Archives/edgar/data/875320/000087532025000232/0000875320-25-000232-index.htm | https://www.sec.gov/Archives/edgar/data/875320/000087532025000232/vrtx-20250930.htm | null | 2026-08-02T22:32:32 | q2WFUM3awWhPVWpQ3 | u1Oo7iedJLPoghB2j | {
"revenue": 12001300000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 3953200000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 25643000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 6977200000,
"totalLiabilitiesFiscalYe... |
0000875320 | VERTEX PHARMACEUTICALS INC / MA | VRTX | Nasdaq | 2834 | Pharmaceutical Preparations | MA | 1231 | operating | 0000875320-25-000216 | 10-Q | 2025-08-05T00:00:00 | 2025-06-30T00:00:00 | 2025-08-05T20:02:33.000Z | null | 000-19319 | 8,896,494 | true | vrtx-20250630.htm | 10-Q | https://www.sec.gov/Archives/edgar/data/875320/000087532025000216/0000875320-25-000216-index.htm | https://www.sec.gov/Archives/edgar/data/875320/000087532025000216/vrtx-20250630.htm | null | 2026-08-02T22:32:32 | q2WFUM3awWhPVWpQ3 | u1Oo7iedJLPoghB2j | {
"revenue": 12001300000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 3953200000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 25643000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 6977200000,
"totalLiabilitiesFiscalYe... |
0000875320 | VERTEX PHARMACEUTICALS INC / MA | VRTX | Nasdaq | 2834 | Pharmaceutical Preparations | MA | 1231 | operating | 0000875320-25-000192 | 10-Q | 2025-05-06T00:00:00 | 2025-03-31T00:00:00 | 2025-05-06T20:04:39.000Z | null | 000-19319 | 7,910,297 | true | vrtx-20250331.htm | 10-Q | https://www.sec.gov/Archives/edgar/data/875320/000087532025000192/0000875320-25-000192-index.htm | https://www.sec.gov/Archives/edgar/data/875320/000087532025000192/vrtx-20250331.htm | null | 2026-08-02T22:32:32 | q2WFUM3awWhPVWpQ3 | u1Oo7iedJLPoghB2j | {
"revenue": 12001300000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 3953200000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 25643000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 6977200000,
"totalLiabilitiesFiscalYe... |
0000875320 | VERTEX PHARMACEUTICALS INC / MA | VRTX | Nasdaq | 2834 | Pharmaceutical Preparations | MA | 1231 | operating | 0000875320-25-000053 | 10-K | 2025-02-13T00:00:00 | 2024-12-31T00:00:00 | 2025-02-13T21:01:52.000Z | null | 000-19319 | 18,532,500 | true | vrtx-20241231.htm | 10-K | https://www.sec.gov/Archives/edgar/data/875320/000087532025000053/0000875320-25-000053-index.htm | https://www.sec.gov/Archives/edgar/data/875320/000087532025000053/vrtx-20241231.htm | null | 2026-08-02T22:32:32 | q2WFUM3awWhPVWpQ3 | u1Oo7iedJLPoghB2j | {
"revenue": 12001300000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 3953200000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 25643000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 6977200000,
"totalLiabilitiesFiscalYe... |
0000875320 | VERTEX PHARMACEUTICALS INC / MA | VRTX | Nasdaq | 2834 | Pharmaceutical Preparations | MA | 1231 | operating | 0000875320-24-000223 | 10-Q | 2024-11-05T00:00:00 | 2024-09-30T00:00:00 | 2024-11-05T21:11:53.000Z | null | 000-19319 | 9,073,073 | true | vrtx-20240930.htm | 10-Q | https://www.sec.gov/Archives/edgar/data/875320/000087532024000223/0000875320-24-000223-index.htm | https://www.sec.gov/Archives/edgar/data/875320/000087532024000223/vrtx-20240930.htm | null | 2026-08-02T22:32:32 | q2WFUM3awWhPVWpQ3 | u1Oo7iedJLPoghB2j | {
"revenue": 12001300000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 3953200000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 25643000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 6977200000,
"totalLiabilitiesFiscalYe... |
0000875320 | VERTEX PHARMACEUTICALS INC / MA | VRTX | Nasdaq | 2834 | Pharmaceutical Preparations | MA | 1231 | operating | 0000875320-24-000198 | 10-Q | 2024-08-02T00:00:00 | 2024-06-30T00:00:00 | 2024-08-02T20:03:02.000Z | null | 000-19319 | 7,933,778 | true | vrtx-20240630.htm | 10-Q | https://www.sec.gov/Archives/edgar/data/875320/000087532024000198/0000875320-24-000198-index.htm | https://www.sec.gov/Archives/edgar/data/875320/000087532024000198/vrtx-20240630.htm | null | 2026-08-02T22:32:32 | q2WFUM3awWhPVWpQ3 | u1Oo7iedJLPoghB2j | {
"revenue": 12001300000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 3953200000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 25643000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 6977200000,
"totalLiabilitiesFiscalYe... |
0000875320 | VERTEX PHARMACEUTICALS INC / MA | VRTX | Nasdaq | 2834 | Pharmaceutical Preparations | MA | 1231 | operating | 0000875320-24-000139 | 10-Q | 2024-05-07T00:00:00 | 2024-03-31T00:00:00 | 2024-05-07T20:14:28.000Z | null | 000-19319 | 7,002,277 | true | vrtx-20240331.htm | 10-Q | https://www.sec.gov/Archives/edgar/data/875320/000087532024000139/0000875320-24-000139-index.htm | https://www.sec.gov/Archives/edgar/data/875320/000087532024000139/vrtx-20240331.htm | null | 2026-08-02T22:32:32 | q2WFUM3awWhPVWpQ3 | u1Oo7iedJLPoghB2j | {
"revenue": 12001300000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 3953200000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 25643000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 6977200000,
"totalLiabilitiesFiscalYe... |
0000875320 | VERTEX PHARMACEUTICALS INC / MA | VRTX | Nasdaq | 2834 | Pharmaceutical Preparations | MA | 1231 | operating | 0000875320-24-000062 | 10-K | 2024-02-15T00:00:00 | 2023-12-31T00:00:00 | 2024-02-15T21:12:14.000Z | null | 000-19319 | 17,149,677 | true | vrtx-20231231.htm | 10-K | https://www.sec.gov/Archives/edgar/data/875320/000087532024000062/0000875320-24-000062-index.htm | https://www.sec.gov/Archives/edgar/data/875320/000087532024000062/vrtx-20231231.htm | null | 2026-08-02T22:32:32 | q2WFUM3awWhPVWpQ3 | u1Oo7iedJLPoghB2j | {
"revenue": 12001300000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 3953200000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 25643000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 6977200000,
"totalLiabilitiesFiscalYe... |
0000875320 | VERTEX PHARMACEUTICALS INC / MA | VRTX | Nasdaq | 2834 | Pharmaceutical Preparations | MA | 1231 | operating | 0000875320-23-000031 | 10-Q | 2023-11-07T00:00:00 | 2023-09-30T00:00:00 | 2023-11-07T21:16:57.000Z | null | 000-19319 | 7,764,057 | true | vrtx-20230930.htm | 10-Q | https://www.sec.gov/Archives/edgar/data/875320/000087532023000031/0000875320-23-000031-index.htm | https://www.sec.gov/Archives/edgar/data/875320/000087532023000031/vrtx-20230930.htm | null | 2026-08-02T22:32:32 | q2WFUM3awWhPVWpQ3 | u1Oo7iedJLPoghB2j | {
"revenue": 12001300000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 3953200000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 25643000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 6977200000,
"totalLiabilitiesFiscalYe... |
0000875320 | VERTEX PHARMACEUTICALS INC / MA | VRTX | Nasdaq | 2834 | Pharmaceutical Preparations | MA | 1231 | operating | 0000875320-23-000021 | 10-Q | 2023-08-02T00:00:00 | 2023-06-30T00:00:00 | 2023-08-02T20:05:15.000Z | null | 000-19319 | 7,804,048 | true | vrtx-20230630.htm | 10-Q | https://www.sec.gov/Archives/edgar/data/875320/000087532023000021/0000875320-23-000021-index.htm | https://www.sec.gov/Archives/edgar/data/875320/000087532023000021/vrtx-20230630.htm | null | 2026-08-02T22:32:32 | q2WFUM3awWhPVWpQ3 | u1Oo7iedJLPoghB2j | {
"revenue": 12001300000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 3953200000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 25643000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 6977200000,
"totalLiabilitiesFiscalYe... |
0000875320 | VERTEX PHARMACEUTICALS INC / MA | VRTX | Nasdaq | 2834 | Pharmaceutical Preparations | MA | 1231 | operating | 0000875320-23-000012 | 10-Q | 2023-05-02T00:00:00 | 2023-03-31T00:00:00 | 2023-05-02T20:07:33.000Z | null | 000-19319 | 7,392,347 | true | vrtx-20230331.htm | 10-Q | https://www.sec.gov/Archives/edgar/data/875320/000087532023000012/0000875320-23-000012-index.htm | https://www.sec.gov/Archives/edgar/data/875320/000087532023000012/vrtx-20230331.htm | null | 2026-08-02T22:32:32 | q2WFUM3awWhPVWpQ3 | u1Oo7iedJLPoghB2j | {
"revenue": 12001300000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 3953200000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 25643000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 6977200000,
"totalLiabilitiesFiscalYe... |
0000875320 | VERTEX PHARMACEUTICALS INC / MA | VRTX | Nasdaq | 2834 | Pharmaceutical Preparations | MA | 1231 | operating | 0000875320-23-000007 | 10-K | 2023-02-10T00:00:00 | 2022-12-31T00:00:00 | 2023-02-10T21:12:03.000Z | null | 000-19319 | 17,192,072 | true | vrtx-20221231.htm | 10-K | https://www.sec.gov/Archives/edgar/data/875320/000087532023000007/0000875320-23-000007-index.htm | https://www.sec.gov/Archives/edgar/data/875320/000087532023000007/vrtx-20221231.htm | null | 2026-08-02T22:32:32 | q2WFUM3awWhPVWpQ3 | u1Oo7iedJLPoghB2j | {
"revenue": 12001300000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 3953200000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 25643000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 6977200000,
"totalLiabilitiesFiscalYe... |
0000318154 | AMGEN INC | AMGN | Nasdaq | 2836 | Biological Products, (No Diagnostic Substances) | DE | 1231 | operating | 0000318154-26-000057 | 10-Q | 2026-05-01T00:00:00 | 2026-03-31T00:00:00 | 2026-04-30T23:04:10.000Z | null | 001-37702 | 9,426,310 | true | amgn-20260331.htm | 10-Q | https://www.sec.gov/Archives/edgar/data/318154/000031815426000057/0000318154-26-000057-index.htm | https://www.sec.gov/Archives/edgar/data/318154/000031815426000057/amgn-20260331.htm | null | 2026-08-02T22:32:34 | q2WFUM3awWhPVWpQ3 | u1Oo7iedJLPoghB2j | {
"revenue": 36751000000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 7711000000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 90586000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"stockholdersEquity": 8658000000,
"stockholdersEquityFisc... |
0000318154 | AMGEN INC | AMGN | Nasdaq | 2836 | Biological Products, (No Diagnostic Substances) | DE | 1231 | operating | 0000318154-26-000010 | 10-K | 2026-02-13T00:00:00 | 2025-12-31T00:00:00 | 2026-02-13T21:07:34.000Z | null | 001-37702 | 20,319,712 | true | amgn-20251231.htm | 10-K | https://www.sec.gov/Archives/edgar/data/318154/000031815426000010/0000318154-26-000010-index.htm | https://www.sec.gov/Archives/edgar/data/318154/000031815426000010/amgn-20251231.htm | null | 2026-08-02T22:32:34 | q2WFUM3awWhPVWpQ3 | u1Oo7iedJLPoghB2j | {
"revenue": 36751000000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 7711000000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 90586000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"stockholdersEquity": 8658000000,
"stockholdersEquityFisc... |
0000318154 | AMGEN INC | AMGN | Nasdaq | 2836 | Biological Products, (No Diagnostic Substances) | DE | 1231 | operating | 0000318154-25-000072 | 10-Q | 2025-11-05T00:00:00 | 2025-09-30T00:00:00 | 2025-11-04T23:59:36.000Z | null | 001-37702 | 10,725,588 | true | amgn-20250930.htm | 10-Q | https://www.sec.gov/Archives/edgar/data/318154/000031815425000072/0000318154-25-000072-index.htm | https://www.sec.gov/Archives/edgar/data/318154/000031815425000072/amgn-20250930.htm | null | 2026-08-02T22:32:34 | q2WFUM3awWhPVWpQ3 | u1Oo7iedJLPoghB2j | {
"revenue": 36751000000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 7711000000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 90586000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"stockholdersEquity": 8658000000,
"stockholdersEquityFisc... |
0000318154 | AMGEN INC | AMGN | Nasdaq | 2836 | Biological Products, (No Diagnostic Substances) | DE | 1231 | operating | 0000318154-25-000056 | 10-Q | 2025-08-06T00:00:00 | 2025-06-30T00:00:00 | 2025-08-05T23:13:42.000Z | null | 001-37702 | 10,781,168 | true | amgn-20250630.htm | 10-Q | https://www.sec.gov/Archives/edgar/data/318154/000031815425000056/0000318154-25-000056-index.htm | https://www.sec.gov/Archives/edgar/data/318154/000031815425000056/amgn-20250630.htm | null | 2026-08-02T22:32:34 | q2WFUM3awWhPVWpQ3 | u1Oo7iedJLPoghB2j | {
"revenue": 36751000000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 7711000000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 90586000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"stockholdersEquity": 8658000000,
"stockholdersEquityFisc... |
0000318154 | AMGEN INC | AMGN | Nasdaq | 2836 | Biological Products, (No Diagnostic Substances) | DE | 1231 | operating | 0000318154-25-000020 | 10-Q | 2025-05-02T00:00:00 | 2025-03-31T00:00:00 | 2025-05-01T22:54:46.000Z | null | 001-37702 | 9,096,767 | true | amgn-20250331.htm | 10-Q | https://www.sec.gov/Archives/edgar/data/318154/000031815425000020/0000318154-25-000020-index.htm | https://www.sec.gov/Archives/edgar/data/318154/000031815425000020/amgn-20250331.htm | null | 2026-08-02T22:32:34 | q2WFUM3awWhPVWpQ3 | u1Oo7iedJLPoghB2j | {
"revenue": 36751000000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 7711000000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 90586000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"stockholdersEquity": 8658000000,
"stockholdersEquityFisc... |
0000318154 | AMGEN INC | AMGN | Nasdaq | 2836 | Biological Products, (No Diagnostic Substances) | DE | 1231 | operating | 0000318154-25-000010 | 10-K | 2025-02-14T00:00:00 | 2024-12-31T00:00:00 | 2025-02-14T21:18:41.000Z | null | 001-37702 | 20,229,552 | true | amgn-20241231.htm | 10-K | https://www.sec.gov/Archives/edgar/data/318154/000031815425000010/0000318154-25-000010-index.htm | https://www.sec.gov/Archives/edgar/data/318154/000031815425000010/amgn-20241231.htm | null | 2026-08-02T22:32:34 | q2WFUM3awWhPVWpQ3 | u1Oo7iedJLPoghB2j | {
"revenue": 36751000000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 7711000000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 90586000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"stockholdersEquity": 8658000000,
"stockholdersEquityFisc... |
0000318154 | AMGEN INC | AMGN | Nasdaq | 2836 | Biological Products, (No Diagnostic Substances) | DE | 1231 | operating | 0000318154-24-000044 | 10-Q | 2024-10-31T00:00:00 | 2024-09-30T00:00:00 | 2024-10-30T22:43:20.000Z | null | 001-37702 | 10,557,832 | true | amgn-20240930.htm | 10-Q | https://www.sec.gov/Archives/edgar/data/318154/000031815424000044/0000318154-24-000044-index.htm | https://www.sec.gov/Archives/edgar/data/318154/000031815424000044/amgn-20240930.htm | null | 2026-08-02T22:32:34 | q2WFUM3awWhPVWpQ3 | u1Oo7iedJLPoghB2j | {
"revenue": 36751000000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 7711000000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 90586000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"stockholdersEquity": 8658000000,
"stockholdersEquityFisc... |
0000318154 | AMGEN INC | AMGN | Nasdaq | 2836 | Biological Products, (No Diagnostic Substances) | DE | 1231 | operating | 0000318154-24-000035 | 10-Q | 2024-08-07T00:00:00 | 2024-06-30T00:00:00 | 2024-08-06T22:54:26.000Z | null | 001-37702 | 11,769,349 | true | amgn-20240630.htm | 10-Q | https://www.sec.gov/Archives/edgar/data/318154/000031815424000035/0000318154-24-000035-index.htm | https://www.sec.gov/Archives/edgar/data/318154/000031815424000035/amgn-20240630.htm | null | 2026-08-02T22:32:34 | q2WFUM3awWhPVWpQ3 | u1Oo7iedJLPoghB2j | {
"revenue": 36751000000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 7711000000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 90586000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"stockholdersEquity": 8658000000,
"stockholdersEquityFisc... |
0000318154 | AMGEN INC | AMGN | Nasdaq | 2836 | Biological Products, (No Diagnostic Substances) | DE | 1231 | operating | 0000318154-24-000020 | 10-Q | 2024-05-03T00:00:00 | 2024-03-31T00:00:00 | 2024-05-02T23:27:57.000Z | null | 001-37702 | 8,956,264 | true | amgn-20240331.htm | 10-Q | https://www.sec.gov/Archives/edgar/data/318154/000031815424000020/0000318154-24-000020-index.htm | https://www.sec.gov/Archives/edgar/data/318154/000031815424000020/amgn-20240331.htm | null | 2026-08-02T22:32:34 | q2WFUM3awWhPVWpQ3 | u1Oo7iedJLPoghB2j | {
"revenue": 36751000000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 7711000000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 90586000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"stockholdersEquity": 8658000000,
"stockholdersEquityFisc... |
0000318154 | AMGEN INC | AMGN | Nasdaq | 2836 | Biological Products, (No Diagnostic Substances) | DE | 1231 | operating | 0000318154-24-000011 | 10-K | 2024-02-14T00:00:00 | 2023-12-31T00:00:00 | 2024-02-14T21:23:32.000Z | null | 001-37702 | 23,081,937 | true | amgn-20231231.htm | 10-K | https://www.sec.gov/Archives/edgar/data/318154/000031815424000011/0000318154-24-000011-index.htm | https://www.sec.gov/Archives/edgar/data/318154/000031815424000011/amgn-20231231.htm | null | 2026-08-02T22:32:34 | q2WFUM3awWhPVWpQ3 | u1Oo7iedJLPoghB2j | {
"revenue": 36751000000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 7711000000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 90586000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"stockholdersEquity": 8658000000,
"stockholdersEquityFisc... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.